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Abstract
Background: Inducible conditional knockout animals are widely used to get insight in the function
of genes and the pathogenesis of human diseases. These models frequently rely on Cre-mediated
recombination of sequences flanked by Lox-P sites. To understand the consequences of gene
disruption, it is essential to know the efficiency of the recombination process.
Results: Here, we describe a modification of the multiplex ligation-dependent probe amplification
(MLPA), called extension-MLPA (eMLPA), which enables quantification of relatively small
differences in DNA that are a consequence of Cre-mediated recombination. eMLPA, here applied
on an inducible Pkd1  conditional deletion mouse model, simultaneously measures both the
reduction of the floxed allele and the increase of the deletion allele in a single reaction thereby
minimizing any type of experimental variation. Interestingly, with this method we were also able to
observe the presence of the excised DNA fragment. This extra-chromosomal deletion-circle was
detectable up to 5 months after activation of Cre.
Conclusion: eMLPA is a novel strategy which easily can be applied to measure the Cre-mediated
recombination efficiency in each experimental case with high accuracy. In addition the fate of the
deletion-circle can be followed simultaneously.
Background
To study the effects of gene disruption in specific tissues
throughout different stages of life, many inducible and
conditional knock-out mouse models have been gener-
ated. The advantage of these models over conventional
knock-out mice is that the gene of interest can be inacti-
vated in the desired tissues at the desired moment, thereby
bypassing embryonic lethality and undesirable side effects
in other tissues. Conditional knockout systems frequently
rely on the recombination of 'floxed' sequences. These are
sequences that are flanked by two specific 34 base pair
sequences, the so-called Lox-P sites [1-3]. Recombination
is caused by the enzyme Cre, resulting in removal of the
intervening sequence and one Lox-P site [1]. When the
expression of Cre is under control of a tissue specific pro-
moter and used in combination with an inducible system,
such as the mutated estrogen receptor ligand-binding
domain (ERT2), targeted genes can be inactivated in the
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desired tissues at different stages of life upon administra-
tion of for instance tamoxifen [4].
To understand the subsequent phenotype it is important
to know the cell-type and the proportion of cells in which
recombination occurred. Reporter models are very suita-
ble to determine 'where' Cre is active, but do not always
provide reliable information on the proportion of cells in
which the target gene will be disrupted. In addition, to
perform for instance gene expression experiments or to
test therapeutic interventions, it is essential to know the
exact proportion of cells in which recombination had
occurred for each individual mouse. The quantification of
the relatively small changes as a result of Cre-mediated
recombination in a subset of cells is challenging and
requires a highly quantitative technique. Although, after
extensive optimization, quantitative PCR (qPCR) has
been used successfully in our group to measure recombi-
nation efficiency in an inducible and conditional knock-
out model [5,6], we sought for an alternative method that
makes it possible to measure all variables in one reaction
and thus yield a higher level of accuracy. For this reason,
we designed a modified form of Multiplex Ligation-
dependant Probe Amplification (MLPA), called exten-
sion-MLPA (eMLPA), with which we can easily quantify
reduction of the floxed allele and increase of the deletion
allele simultaneously, thereby minimizing the experimen-
tal variation.
The earlier described MLPA technique, commonly used in
diagnostics to detect copy number variations in genomic
DNA, uses probe-pairs that contain target specific and
universal sequences [7]. These probe-pairs are hybridized
immediately adjacent to each other onto the target DNA
and after ligation, templates of unique sizes are generated.
These templates contain universal sequences at both ends
and can be amplified using a single primer pair. The
strength of MLPA is that it enables the analysis of multiple
genomic loci in a single reaction. In the case of condi-
tional knock-out models however, the presence of a com-
mon Lox-P site impedes the simultaneous measurement
of the floxed and deletion alleles. Adjustment of MLPA by
an additional extension reaction, makes it possible to dis-
tinguish the different fragments and to quantify them in
one reaction.
The principle of eMLPA was tested on a mouse model for
Autosomal Dominant Polycystic Kidney Disease, contain-
ing the tamoxifen-inducible KspCad-Cre-ERT2 construct,
hereafter Cre, and the floxed Pkd1 allele (Pkd1lox2-11) [5,6].
In these mice Cre is expressed in the kidneys in the epithe-
lial cells of all tubular segments of the nefrons. Upon
administration of tamoxifen, Cre translocates from the
cytoplasm to the nucleus and converts the Pkd1lox2-11
allele, hereafter Pkd1lox, to the Pkd1del2-11 allele. Using
eMLPA, recombination efficiency was determined with
high accuracy and reproducibility.
Additionally, the excised and circularized fragment that
results from Cre-mediated recombination could also be
detected, even five months after recombination was
induced.
Results
With the aim to get a more accurate measurement of Cre-
mediated recombination in inducible and conditional
knock-out mice, we have set up the extension MLPA
(eMLPA) to quantify in one reaction, the mixture of alleles
that are a result of Cre-mediated recombination. The ear-
lier described MLPA technique is able to quantify multiple
targets on a DNA template in a single reaction [7]. How-
ever, in the regular MLPA strategy, the probes will not be
able to discriminate between the floxed and the deletion
allele due to the presence of a common Lox-P site. In addi-
tion, since the Lox-P site is a palindrome, probes designed
directly on the Lox-P site are likely to fail. Therefore,
MLPA was modified in such a way that the alleles can be
distinguished.
eMLPA strategy
The eMLPA strategy is outlined in Figure 1. Instead of
designing the probes adjacent to each other, the probes
were designed around the Lox-P sites. Probes A and B are
located 46 bp from each other flanking the Lox-P site in
intron 1 of the Pkd1 gene, and probes C and D are located
47 bp from each other flanking the Lox-P site in intron 11
(Figure 1). In regular MLPA the next step would be the
ligation of the neighbouring probes to generate a template
for PCR. In eMLPA however, a polymerase is required to
fill in the gaps. Most DNA polymerases harbor besides 5'-
3' polymerase activity, also 5'-3' exonuclease or strand-
displacement activity. Since these activities will degrade or
displace the right probe, no template for the PCR-reaction
could be generated, leading to failure in the eMLPA strat-
egy (not shown). The Stoffel fragment of Taq-polymerase
has been reported to lack 5'-3' exonuclease or strand-dis-
placement activities [8]. However, the optimum tempera-
ture of Stoffel-Taq is 72°C, which is slightly above the
melting temperature of most of the probes. Unsurpris-
ingly, no peaks were observed when the extension reac-
tion was carried out at 72°C (not shown). Since the
ligation reaction is performed at 54°C we combined the
extension with the ligation reaction at that temperature,
just by adding Stoffel-Taq and dNTP's to the ligation mix-
ture. Already the addition of 0.1 U Stoffel-Taq and 2 mM
of dNTP's to the ligation mixture resulted in strong peaks
of the expected sizes after 29 rounds of amplification (Fig-
ure 2). The signals seem to increase somewhat up to 1 U
of Stoffel-Taq, but did not change significantly when
increasing amounts of Stoffel-Taq up to 10 U were addedBMC Biotechnology 2008, 8:18 http://www.biomedcentral.com/1472-6750/8/18
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(not shown). To quantify the recombination efficiency in
our inducible conditional mouse model we used 1 U Stof-
fel-Taq in the extension reaction.
Quantification of recombination efficiency by eMLPA, in 
inducible and conditional Pkd1 mice
In mice having one or two Pkd1lox alleles and the Cre
transgene, deletion of the floxed gene can be induced in
the kidneys by administration of Tamoxifen. If recombi-
nation occurs, the ratio of the peaks corresponding to the
floxed and deletion alleles, changes. This ratio is fixed and
should be stable among Pkd1del2-11, lox mice lacking Cre.
These mice carry one Pkd1-deletion allele in the germ-line
[9], meaning that all cells contain one deletion allele.
Therefore, in each experiment, we calculated the median
of the ratios of eight Pkd1del2-11, lox mice, which served as a
fifty percent reference. To validate eMLPA, we included a
dilution series in steps of ten percent ranging from a hun-
dred to zero percent, by diluting DNA from embryonic
mice with two Pkd1del-11 alleles with DNA from mice con-
taining two Pkd1lox alleles. By relating the peak-ratios to
the fifty percent reference, the Pkd1del-11 percentages from
each sample could be calculated (Figure 3). The measured
percentages from all samples with a known proportion of
Pkd1del-11 allele resembled the expected values within a
five percent interval (Figure 4). This demonstrates that
eMLPA is well suited to quantify the amount of recom-
bined allele ranging from zero to a hundred percent with
high reproducibility.
In addition, samples from tamoxifen treated neonatal or
adult Cre; Pkd1del2-11, lox, Cre; Pkd1lox,+, and Cre; Pkd1lox, lox
mice were analyzed. The results indicate that adult Cre;
Pkd1del2-11, lox and Cre; Pkd1lox,+ mice that were treated with
tamoxifen, gained 20–25% extra Pkd1del2-11 allele, mean-
ing that in 40–50% of renal cells recombination had
occurred. Neonatal Cre; Pkd1del2-11, lox and Cre; Pkd1lox,+
mice that were treated with tamoxifen, gained approxi-
mately 3–8% extra Pkd1del2-11 allele, indicating that in 6–
16% of renal cells recombination had occurred. Neonatal
Cre;  Pkd1lox, lox mice that were treated with tamoxifen,
gained 14–21% extra Pkd1del2-11 allele.
The data obtained by eMLPA are in line with the previous
reported qPCR data (Figure 5A) [5,6]. However even after
extensive optimization and selection of optimal primer
sets out of at least six different primer combinations for
both the deletion specific and the reference PCR, qPCR
seemed to be more susceptible to random and systematic
errors then eMLPA. In a typical experiment we now use
two or three eMLPA hybridizations on which a single PCR
is performed, while qPCR was performed three times in
triplicate.
The eMLPA strategy Figure 1
The eMLPA strategy. (A) The position of the probes A, 
B, C, and D in case of the Pkd1lox allele or the Pkd1del2-11 allele 
after hybridization. (B) The gap between probes is filled in 
using Stoffel-Taq Polymerase. (C) The remaining nick is 
ligated by ligase, completing the formation of the templates 
AB, CD, and AD which are amplified simultaneously in a PCR 
reaction containing a fluorescently labeled forward primer.
The AB, CD and AD peaks obtained after capillary gel elec- trophoresis Figure 2
The AB, CD and AD peaks obtained after capillary 
gel electrophoresis. When only the Pkd1lox allele is 
present two peaks, AB and CD, can be observed (Upper 
panel). A single peak, AD, is observed when only the Pkd1del2-
11 allele is present (Middle panel). When the Pkd1lox and the 
Pkd1del2-11 allele are both present, all three peaks can be 
observed (Lower panel).BMC Biotechnology 2008, 8:18 http://www.biomedcentral.com/1472-6750/8/18
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In this study, DNA from Pkd1del2-11, lox mice was used as a
fifty percent reference. However, when DNA from hetero-
zygous deletion-mice is not available, an alternative refer-
ence should be established. For this purpose, a probe set
has to be selected on a control locus, which can be any
locus outside the recombination area, and should be used
in addition to the probes for detection of the floxed allele.
Similar to regular MLPA that is used to measure copy
number variation, the peak-height of the control locus is
related to the peak-heights of the floxed locus. The ratio
between these peaks will then serve as a hundred percent
reference in mice homozygous and as a fifty percent refer-
ence in mice heterozygous for the floxed allele. After
recombination, the reduction of the floxed allele can be
quantified by comparing the altered Lox-P/control peak-
ratio with this reference.
Characterization of random and systematic errors in qPCR 
and eMLPA
While random errors manifest themselves as large error
bars, systematic errors will display a value significantly
different from the true value. The latter may lead to false
conclusions when samples with an unknown value need
to be analyzed. To analyze potential variation, eMLPA and
qPCR data from six Pkd1del2-11, lox mice, which have exactly
50% Pkd1del2-11 allele, were compared. The raw data from
five different experiments were combined and the median
was calculated. For the individual measurements, percent-
ages were calculated relative to the median. The variation
observed in qPCR was considerably larger compared to
the variation seen in eMLPA (Figure 5B).
We further investigated the influence of lower DNA con-
centrations on the performance of eMLPA. Single hybrid-
izations were carried out on 500 ng, 25 ng or 10 ng of
DNA from eight Pkd1del2-11, lox mice, followed by exten-
sion and ligation. From this reaction (in total 40 ul), 5 ul
was used for PCR. Since 29 cycles of amplification was not
sufficient to obtain considerable peaks at the lower DNA
Outline for calculating the percentage of deletion allele Figure 3
Outline for calculating the percentage of deletion 
allele. The percentage of Pkd1del2-11 for a sample s1 is used 
as an example. (A) The peak-ratios (P) for all controls and 
sample s1 is calculated by dividing the height of the deletion 
peak with the sum of the lox peaks. (B) A fifty percent refer-
ence (Ref.) is calculated by taking the median of the peak-
ratios from all controls. (C) The peak-ratio for sample 1 
(Ps1) is divided by and thus normalized to the fifty percent 
reference. The ratio of the Pkd1del2-11 allele to the Pkd1lox 
allele in sample 1 is, Rs1 to 1. (D) Thus, the fraction of the 
Pkd1del2-11 allele relative to the sum of the Pkd1del2-11 and 
Pkd1lox alleles is Rs1 divided by Rs1 plus 1. The total percent-
age of Pkd1del2-11 in sample 1 (Ds1) can now be calculated by 
multiplying this fraction with the maximum percentage (M) 
the Pkd1del2-11 and Pkd1lox alleles can have together. M is 
either 50% when initially one Pkd1lox and one Pkd1+ allele are 
present or a 100% when both alleles were either Pkd1lox or 
Pkd1del2-11.
Quantification of the percentage of Pkd1del2-11 allele by  eMLPA Figure 4
Quantification of the percentage of Pkd1del2-11 allele 
by eMLPA. To validate the eMLPA strategy, the percentage 
of Pkd1del2-11 allele is shown for eight Pkd1del2-11, lox controls 
with an expected value of 50%, and for a dilution series rang-
ing from a hundred to zero percent of Pkd1del2-11 allele, 
obtained by diluting Pkd1del2-11, del2-11 with Pkd1lox, lox DNA at 
different ratios. All controls and samples from the dilution 
series gave the expected results within a five percent inter-
val. The percentage of Pkd1del2-11 allele is also measured in 
adult or neonatal tamoxifen treated Cre; Pkd1lox,+, Cre; 
Pkd1del2-11, lox and Cre; Pkd1lox, lox mice. The error bars repre-
sent the standard error of the mean. Hybridizations were 
performed three times and PCR's were performed in tripli-
cate on each hybridization.BMC Biotechnology 2008, 8:18 http://www.biomedcentral.com/1472-6750/8/18
Page 5 of 9
(page number not for citation purposes)
Characterization of experimental errors in eMLPA and qPCR Figure 5
Characterization of experimental errors in eMLPA and qPCR. (A) Correlation of eMLPA and qPCR. To verify 
eMLPA, data obtained from samples analyzed with both qPCR and eMLPA are plotted against each other. (B) Inter-experimen-
tal variation in heterozygous control (Pkd1del2-11, lox) mice is presented. Raw data from five different eMLPA or qPCR experi-
ments were combined. The percentage of Pkd1 deletion, which should be exactly 50%, was calculated relative to the median of 
all measurements. An eMLPA experiment consists of two or three hybridizations on which a single PCR was performed and a 
qPCR experiment consists of a triplo PCR. Each point shown is an average of these duplo or triplo measurements and the 
error bars represent the standard error of the mean. (C) The performance of eMLPA at low DNA concentrations. Single 
hybridizations were carried out on 500 ng, 25 ng or 10 ng of DNA from eight Pkd1del2-11, lox mice, followed by extension, liga-
tion and 29, 33 or 35 cycles of amplification respectively. Pkd1del2-11 percentages were calculated relative to the median from 
the 500 ng hybridizations which was used as the 50% reference. From the eight Pkd1del2-11, lox samples in each group; the 500 ng, 
25 ng and the 10 ng hybridizations, the median and standard deviations from the Pkd1del2-11 percentages are shown. Whereas 
the median from both groups at the lower DNA concentrations is close to the expected 50%, the variation in these groups is 
higher.BMC Biotechnology 2008, 8:18 http://www.biomedcentral.com/1472-6750/8/18
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concentrations, the 25 ng and the 10 ng hybridizations
were amplified for 33 and 35 cycles respectively. The
Pkd1del2-11 percentages were calculated using the median
from the 500 ng hybridizations as the 50% reference.
Next, the median and standard deviations were calculated
from the eight Pkd1del2-11, lox samples for each group (Fig-
ure 5C). The median obtained from the groups with the
lower DNA concentrations were close to the expected
50%, indicating that peak-ratios are not significantly
influenced by lower DNA concentrations combined with
more cycles of amplification as described previously [10].
Although more variation is seen at lower DNA concentra-
tions, a single PCR on a single hybridization on only 10
ng of DNA, can already give an estimation of the recombi-
nation efficiency. More accurate results at low DNA con-
centrations may be obtained when more PCR reactions
are performed on the same hybridization.
Detection of the circular extra-chromosomal deletion 
product of Cre
Beside the peaks corresponding to the Pkd1lox  and
Pkd1del2-11 alleles, tamoxifen induced Ksp-CreERT2 mice
having one or two Pkd1lox alleles showed an additional
144 bp peak, of variable height (Figure 6A). In mice that
were left untreated or lacked the Ksp-CreERT2 transgene
this peak was never observed. We investigated the possi-
bility that this extra peak originated from the circular
extra-chromosomal deletion product, hereafter the dele-
tion-circle, of the recombination process [1]. Only when
this excised floxed DNA fragment is present in a circular
configuration (Figure 6B) probes B and C potentially can
form a 144 bp product. Indeed, when eMLPA was carried
out using just probes B and C, only in the samples in
which recombination occurred, a clear product was
detected after agarose-gel-electrophoresis (Figure 6C). To
confirm that this product originated from the extra-chro-
mosomal deletion-circle, sequence analysis in both direc-
tions of the B to C product was carried out. The B to C
sequence exactly matched the sequence that would be
expected from the floxed DNA fragment when excised and
circularized by Cre-recombinase.
Discussion
To understand the function of genes inactivated by Cre-
mediated recombination and the resulting phenotypes, it
is essential to know the exact location as well as the effi-
ciency of the recombination events. This can be achieved
by histological analysis of the target protein by antibody
staining but will only be possible when an excellent anti-
body is available and the expression is high enough. The
generation of reporter models, capable of visualizing Cre
activity by expressing fluorescent proteins, or proteins that
can be easily detected via enzymatic reactions, allows the
localization of active Cre but may not provide reliable
knowledge about the recombination efficiency in each
Detection of the deletion-circle as a result of Cre-mediated  recombination Figure 6
Detection of the deletion-circle as a result of Cre-
mediated recombination. (A) An example of the four 
observed peaks in an adult tamoxifen treated Cre; Pkd1del2-11, 
lox mouse, three peaks corresponding to the Pkd1lox and 
Pkd1del2-11 alleles plus an additional 144 bp peak. (B) The pos-
sible locations of probes B and C on the Pkd1lox allele and on 
the deletion-circle. Probes B and C can only form a product 
when the floxed fragment is excised and circularized by Cre. 
(C) Hybridization of probes B and C followed by extension, 
ligation, 36 cycles of amplification and agarose-gel-electro-
phoresis does not result in a product when DNA from two 
Pkd1del2-11, lox mice was used, but when DNA from kidneys 
from two adult tamoxifen treated Cre; Pkd1del2-11, lox mice 
was used as a template, a distinct product of 144 bp was 
observed.BMC Biotechnology 2008, 8:18 http://www.biomedcentral.com/1472-6750/8/18
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individual case, due to variability in the efficiency of Cre
between different floxed loci, induction protocols, devel-
opmental stages, genetic backgrounds or even between lit-
termates [5,6,11,12]. However, once the location has
been established, alternative methods may be used to
determine the recombination efficiency of the target locus
in individual mice.
Since Cre-mediated recombination may result in the con-
version of a floxed allele to a deletion allele only in a sub-
set of cells, the changes to be measured are usually subtle
and thus require a highly quantitative and robust tech-
nique. To quantify Cre-mediated recombination, south-
ern and western blotting for example can be used but
require a relatively high amount of DNA or protein, are
labor-intensive and will not be able to detect small differ-
ences with sufficient reliability. More commonly nowa-
days, qPCR has been applied, a method that is generally
used to detect two or more fold differences. We success-
fully applied qPCR to measure the percentage of Pkd1del2-
11 allele [5,6]. However, despite the use of high-quality
DNA as assessed by nanodrop measurements and exten-
sive optimizations, qPCR seemed to be susceptible to ran-
dom and systematic errors. Presumably, since signals
from different reactions, a reference PCR and a deletion
specific PCR, are compared to each other. In this paper we
describe and validate the eMLPA technique, a novel strat-
egy which can be used in a 96-well format and measures
all parameters in a single reaction, allowing all possible
information within a sample to be retrieved and experi-
mental variation to be minimized.
Although regular MLPA is also able to measure multiple
loci in one reaction, it cannot measure the floxed and the
deletion allele simultaneously, due to the presence of a
common Lox-P site. Furthermore, when the extra-chro-
mosomal deletion-circle is still present, MLPA will not be
able to distinguish this fragment from the floxed allele,
making it impossible to measure the reduction of the
floxed allele. The results obtained by eMLPA will not be
affected by the deletion-circle, provided that the different
fragment sizes do not overlap with each other. Probes
should therefore be selected in such a way that all loci to
be tested, including the possible deletion-circle, will result
in peaks of different sizes. With eMLPA we could repro-
ducibly quantify the recombination efficiency in our Pkd1
conditional knockout model using 300 to 500 ng of DNA.
However, also at lower DNA concentrations of 10 to 25 ng
per hybridization, especially relevant when working with
small specimens, valuable information on the recombina-
tion efficiency can be obtained by increasing the amount
of cycles of amplification and perform more PCR reac-
tions on a single hybridization. Although, as described
previously [10] relative signal intensities between peaks
did not change significantly by varying the amount of
cycles in the PCR and the inter-experimental variation in
eMLPA is considerably smaller compared with qPCR, we
recommend including a set of six to eight control samples
in each experiment to obtain a reliable reference.
We observed differences in recombination efficiencies
between adult and newborn mice. Since newborn mice
received tamoxifen in the milk via weaning mothers and
adult mice directly through a feeding needle, adult mice
may receive higher concentrations of tamoxifen. In addi-
tion we also measured two-fold higher Cre-expression in
adult mice [6]. Other explanations however, like differ-
ences in tissue composition, cannot be ruled out [6].
Using eMLPA, we could clearly detect the deletion-circle,
even five months after activation of Cre by tamoxifen. In
Pkd1del2-11, lox mice, carrying the deletion allele in the germ
line and lacking Cre, this fragment was not detected. Since
the deletion-circle lacks an origin of replication it is
unlikely that it will be replicated during cell-division.
However, in non-dividing cells, the deletion-circle appar-
ently can be stable for a long time without being
degraded, a phenomenon which also has been seen in
plants and in Drosophila but, to the best of our knowledge,
has not yet been reported for mouse models [13,14]. Even
more, the Drosophila white gene on the extra-chromo-
somal circle was expressed in the eyes during a substantial
period of time and the expression could increase after
excision [14]. Therefore, when larger DNA fragments are
excised containing entire genes that potentially could be
transcribed, it may be desirable to follow the fate of the
excised fragment. We observed variability in the height of
the peak that corresponded to the deletion-circle. This
may be explained by the type of DNA-isolation protocol
that we used, designed to isolate high-molecular genomic
DNA, but could also result from variation in proliferation
between different mice. Upon isolation of total DNA, it
should be possible to simultaneously quantify the recom-
bination efficiency and the amount of circular excised
fragment using eMLPA.
In addition, to the Pkd1 inducible and conditional knock-
out model, eMLPA was used to measure recombination
efficiency of the Fc gamma RII gene, in a B-cell specific
inducible Cre mouse-model. In this model the recombi-
nation efficiency in spleen, measured by eMLPA, resem-
bled the level of Fc gamma RII protein in B-cells as
quantified by FACS-analysis. Even more, also in these
samples the deletion circle was clearly detectable (Borros
et al. manuscript in preparation).
Conclusion
eMLPA is a novel method, set up to measure Cre-mediated
recombination, which has the advantage to measure gene
disruption in a relatively small fraction of cells with highBMC Biotechnology 2008, 8:18 http://www.biomedcentral.com/1472-6750/8/18
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accuracy. Additionally, the fate of the excised DNA frag-
ment can be followed simultaneously. eMLPA can be
applied on a large number of samples, is easy to set up and
requires equipment present in most labs.
Methods
Sample preparation
Tamoxifen treatment has been described previously [5].
Adult mice, 3–4 months of age, have been treated with 5
mg tamoxifen for 3 consecutive days, using a feeding nee-
dle. Weaning mothers, 3–6 months old, received a similar
treatment starting at postnatal day 4 (PN4) of the prog-
eny, and these newborn mice received tamoxifen via
breast-feeding from the mother. Mice were sacrificed one
to five months after tamoxifen administration and kid-
neys were collected and snap-frozen in liquid nitrogen
from Pkd1del2-11, lox, Pkd1lox, lox or Pkd1lox,+ mice, treated or
untreated with tamoxifen, depending on the presence or
absence of the KspCad-Cre-ERT2 transgene. Also 14-day-
old embryos were used in order to obtain Pkd1del2-11, del2-
11 material. To simultaneously isolate DNA as well as total
RNA, for possible future gene expression analysis, kidneys
were homogenized in 500 µl 1% 2-mercaptoethanol in
PBS, using the magNA lyser (Roche). To isolate total RNA,
750 µl Tri-Reagent (Sigma-Aldrich The Netherlands) was
added to 250 µl of the homogenate, after which the man-
ufacturers' protocol was further followed. The remaining
part of the homogenate was used to isolate DNA using AX-
G100 columns (Bioké, Leiden, The Netherlands) accord-
ing to the manufacturers' protocol. From a minority of
samples we only isolated DNA. These samples were
homogenized in Buffer G2 (Bioké, Leiden, The Nether-
lands) with an ultra-thurax and DNA was isolated as
described above.
All experiments using mice were approved by the local
animal experimental committee of the Leiden University
Medical Center and by the Commission Biotechnology in
Animals of the Dutch Ministry of Agriculture.
Probe design
Two probes, A and B, were designed to detect the Lox-P
site in intron 1 of the Pkd1 gene (Lox 1) and two other
probes, C and D, to detect the Lox-P site in intron 11 (Lox
2.) (Figure 1A). In addition to the target specific sequence,
the left probe from each probe pair contains a 19 nt
sequence on its 5' end, similar to the sequence of the
labeled forward primer used in the PCR and the right
probe from each pair contains the target sequence for the
reverse primer on its 3' end. The primers used are the
MLPA-primers described by Schouten et al. [7]. Further-
more, all probes were designed to have a melting temper-
ature above 69°C, a GC content between 35 and 60
percent (determined by free to download software: Raw-
probe, from MRC-Holland; Amsterdam, The Nether-
lands) and the right probes were phosphorylated on their
5' end. All probes were obtained from BioLegio
(Nijmegen, the Netherlands) and sequences are available
upon request. The product AD will be formed when the
Pkd1del2-11 allele is present. The products AB, CD and AD,
differ four nucleotides in length so that they can be distin-
guished when run over a capillary sequencer. Due to the
palindromic sequence of the Lox-P site, probes were
designed around these sequences leaving a gap between
the left and right probe that can be filled in during the
extension reaction. This process is outlined in Figure 1B
and 1C.
eMLPA reaction
5 µl of 60–100 ng/µl DNA samples were heated at 98°C
for 5 minutes and then placed on ice. Hybridizations were
performed by adding 1.5 µl MLPA buffer (MRC-Holland;
Amsterdam, The Netherlands) and 1.5 µl probe mix, con-
taining a probe concentration of 4 nM, heating the sam-
ples at 95°C for 5 minutes followed by a 4 hour
hybridization step at 60°C.
The extension and ligation reactions were performed
simultaneously by adding 2 mM dNTP's and 1 U Stoffel
Taq polymerase (Applied Biosystems) for the extension,
and 3 µl Buffer A, 3 µl buffer B, 1 µl Ligase-65 (MRC-Hol-
land) for the ligation, to a total volume of 40 µl while the
samples and the extension/ligation mixture were pre-
incubated at 54°C. The reactions were performed at 54°C
for 25 minutes followed by the inactivation of the ligase
at 95°C for 5 minutes. 5 µl of the samples was used in a
25 µl PCR reaction containing 1 µl primer-mix and 1 U
Salsa polymerase (MRC-Holland) in 45 mM Tris-HCl
pH8.5, 11 mM (NH4)2SO4, 4.5 mM MgCl2, 5 µM EDTA,
0.5 mM dNTP's and 0.11 mg/ml Bovine serum albumin
(Fraction 5). The PCR reaction consisted of 29 rounds of
amplification (30 s at 95°C, 30 s at 60°C, 45 s at 72°C).
2 µl of the amplified samples were mixed with 10 µl Hi-
Di Formamide containing GeneScan-500 ROX size stand-
ard (Applied Biosystems) and run on a 3730 DNA ana-
lyzer (Applied Biosystems).
eMLPA data analysis
For data analysis GeneScan analysis 3.5 and Microsoft
Excel software were used.
The samples (s1, s2....sn) in each experiment consisted of
DNA from kidneys from Cre; Pkd1del2-11, lox or Cre;
Pkd1lox,+  mice in which an unknown amount of the
Pkd1lox allele has been converted to the Pkd1del2-11 allele.
To calculate the total percentage of Pkd1del2-11 allele in
these samples, a fifty percent reference was used. This ref-
erence was calculated from controls (c1, c2....cn), consist-
ing of DNA from kidneys from Pkd1del2-11, lox mice, having
a fixed amount of 50% deletion allele.Publish with BioMed Central    and   every 
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First, the peak-ratios (P) were calculated for all samples
and controls by dividing the height of the deletion peak
by the sum of the heights of the two lox peaks, resulting
in (Ps1, Ps2.... Psn) for the samples and (Pc1, Pc2.... Pcn) for
the control samples (Figure 3A).
Since the controls harbor exactly fifty percent Pkd1del2-11
allele, the peak-ratios found in the controls represent fifty
percent Pkd1del2-11 allele. To calculate a robust fifty percent
reference (Ref.), the median was obtained from the peak-
ratios of the controls (Figure 3B).
All peak-ratios could then be normalized by dividing the
peak-ratios with the fifty percent reference, resulting in the
actual Pkd1del2-11 to Pkd1lox ratio (R) (Figure 3C). Ideally,
all controls should have an R-value of one, representing a
Pkd1del2-11 to Pkd1lox ratio of 1:1.
From this ratio, the total percentage of Pkd1del2-11 (D)
could be calculated by dividing the Pkd1del2-11 fraction (R)
with the sum of the Pkd1del2-11 and Pkd1lox fractions (R +
1) which is then multiplied by the maximum percentage
(M) of the Pkd1del2-11 and Pkd1lox alleles together (Figure
3D). When both alleles are either Pkd1del2-11 or Pkd1lox, M
is a hundred percent and when one wild-type allele is
present, M is fifty percent.
Quantitative PCR
qPCR was performed as described previously [5,6]. The
Pkd1del2-11 specific PCR was carried out using primers that
were selected in intron 1 and intron 11 flanking the dele-
tion, and compared to a reference PCR in which a frag-
ment of exon 36 of the undeleted distal part of the Pkd1
gene was amplified. DNA isolated from Pkd1del2-11, lox
mice, containing 50% Pkd1del2-11 allele, was used as a 50%
reference. All measurements were performed three times
in triplicate.
Authors' contributions
WNL contributed to the conceptual idea, carried out the
experiments and drafted the manuscript. JHR contributed
to the conceptual idea of the eMLPA. ISLL provided the
animal model on which the study was performed. MHB
participated in coordination. DJMP participated in coor-
dination, discussion and helped writing the manuscript.
All authors have read and approved the final manuscript.
Acknowledgements
We kindly thank the group of Sjef Verbeek for critical reading the manu-
script and for permission to mention their data obtained with eMLPA.
This research was supported by grants from the Dutch Kidney Foundation 
(NSN C04-2086 and C05-2132) and the Netherlands Organization for Sci-
entific Research (NWO 917.36.353)
References
1. Sauer B, Henderson N: Site-specific DNA recombination in
mammalian cells by the Cre recombinase of bacteriophage
P1.  Proc Natl Acad Sci USA 1988, 85:5166-5170.
2. Branda CS, Dymecki SM: Talking about a revolution: The
impact of site-specific recombinases on genetic analyses in
mice.  Dev Cell 2004, 6:7-28.
3. Claij N, Peters DJM: Transgenesis and gene targeting: mouse
models to study gene function and expression.  Pediatr Nephrol
2006, 21:318-323.
4. Indra AK, Warot X, Brocard J, Bornert JM, Xiao JH, Chambon P,
Metzger D: Temporally-controlled site-specific mutagenesis
in the basal layer of the epidermis: comparison of the recom-
binase activity of the tamoxifen-inducible Cre-ER(T) and
Cre-ER(T2) recombinases.  Nucleic Acids Res 1999, 27:4324-4327.
5. Lantinga-van Leeuwen IS, Leonhard WN, van der Wal A, Breuning
M H ,  D e  H e e r  E ,  P e t e r s  D J M :  Transgenic mice expressing
tamoxifen-inducible Cre for somatic gene modification in
renal epithelial cells.  Genesis 2006, 44:225-232.
6. Lantinga-van Leeuwen IS, Leonhard WN, van der Wal A, Breuning
MH, De Heer E, Peters DJM: Kidney-specific inactivation of the
Pkd1 gene induces rapid cyst formation in developing kid-
neys and a slow onset of disease in adult mice.  Hum Mol Genet
2007, 16:3188-3196.
7. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F,
Pals G: Relative quantification of 40 nucleic acid sequences by
multiplex ligation-dependent probe amplification.  Nucleic
Acids Res 2002, 30:e57.
8. Lawyer FC, Stoffel S, Saiki RK, Chang SY, Landre PA, Abramson RD,
Gelfand DH: High-level expression, purification, and enzy-
matic characterization of full-length Thermus aquaticus
DNA polymerase and a truncated form deficient in 5' to 3'
exonuclease activity.  PCR Methods Appl 1993, 2:275-287.
9. Lantinga-van Leeuwen IS, Dauwerse JG, Baelde HJ, Leonhard WN,
van der Wal A, Ward CJ, Verbeek S, DeRuiter MC, Breuning MH, De
Heer E, Peters DJM: Lowering of Pkd1 expression is sufficient
to cause polycystic kidney disease.  Hum Mol Genet 2004,
13:3069-3077.
10. Eldering E, Spek AC, Aberson HL, Grummels A, Derks IA, de Vos AF,
McElgunn CJ, Schouten JP: Expression profiling via novel multi-
plex assay allows rapid assessment of gene regulation in
defined signalling pathways.  Nucleic Acids Res 2003, 31:e153.
11. Soriano P: Generalized lacZ expression with the ROSA26 Cre
reporter strain.  Nat Genet 1999, 21:70-71.
12. Novak A, Guo C, Yang W, Nagy A, Lobe CG: Z/EG, a double
reporter mouse line that expresses enhanced green fluores-
cent protein upon Cre-mediated excision.  Genesis 2000,
28:147-155.
13. Srivastava V, Ow DW: Rare instances of Cre-mediated deletion
product maintained in transgenic wheat.  Plant Mol Biol 2003,
52:661-668.
14. Ahmad K, Golic KG: Somatic reversion of chromosomal posi-
tion effects in Drosophila melanogaster.  Genetics 1996,
144:657-670.